GLP-1 Market
LLY $1143.12 ▲ +0.0% NVO $37.54 ▲ +0.6% PFE $27.41 ▼ -1.4% VKTX $29.28 ▼ -2.2% KLRA $10.84 ▲ +4.3% GPCR $27.59 ▼ -0.3% RHHBY $52.51 ▲ +0.5%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Pharmacokinetics study

Company
Assistance Publique - Hôpitaux de Paris
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
13 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

13 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 6, 2026

Find a Clinical Trial Near Me

See recruiting studies for Pharmacokinetics study and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03717623

    Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants

    Not yet reported Melbourne Health 100 participants Est. completion 2025-12-30 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Pharmacokinetics, Invasive Candidiases, Invasive Aspergillosis, Invasive Mycosis, Fungal Infection, Prophylaxis
    View official trial listing →
  • Recruiting NCT NCT05491525

    Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

    Not yet reported, Not yet reported Urovant Sciences GmbH 71 participants Est. completion 2030-09 38 sites
    Other conditions: Neurogenic Detrusor Overactivity
    View official trial listing →
  • Recruiting NCT NCT05588323

    Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids

    Not yet reported, Not yet reported Shionogi 24 participants Est. completion 2028-06-15 16 sites
    Other conditions: Opioid-Induced Constipation (OIC)
    View official trial listing →
  • Recruiting NCT NCT06100744

    A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

    Not yet reported AbbVie 40 participants Est. completion 2028-10 34 sites
    Other conditions: Juvenile Psoriatic Arthritis
    View official trial listing →
  • Recruiting NCT NCT06357377

    A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

    Not yet reported Neonc Technologies, Inc. 12 participants Est. completion 2027-07 1 site
    Other conditions: Pediatric Tumor of CNS, Pediatric Tumor of Brain, Diffuse Midline Glioma, H3 K27M-Mutant, Pediatric Tumor of Brain Stem, Pineocytoma, Choroid Plexus Carcinoma, Childhood, Spinal Cord Tumor, High Grade Glioma
    View official trial listing →
  • Recruiting NCT NCT06429930

    Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults

    Not yet reported Pharmosa Biopharm Inc. 40 participants Est. completion 2026-12-31 1 site
    Other conditions: Healthy Adult Participants
    View official trial listing →
  • Recruiting NCT NCT06517693

    Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2028-06-30 17 sites
    Other conditions: HIV-1
    View official trial listing →
  • Recruiting NCT NCT06533579

    Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

    Not yet reported, Not yet reported Vironexis Biotherapeutics Inc. 32 participants Est. completion 2031-09 11 sites
    Other conditions: B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Burkitt Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Non Hodgkin Lymphoma, Mixed Phenotype Acute Leukemia
    View official trial listing →
  • Recruiting NCT NCT06815575

    A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.

    Not yet reported Racura Oncology Ltd 53 participants Est. completion 2029-01-31 9 sites
    Other conditions: Solid Tumours, Advanced Solid Tumours
    View official trial listing →
  • Recruiting NCT NCT07303621

    Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric Population

    Hospices Civils de Lyon 150 participants Est. completion 2027-08-09 1 site
    Other conditions: Cystic Fibrosis (CF)
    View official trial listing →
  • Recruiting NCT NCT07346859

    Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)

    Not yet reported Biopharma Plasma LLC 56 participants Est. completion 2028-07-01 12 sites
    Other conditions: Primary Immunodeficiency Diseases
    View official trial listing →
  • Recruiting NCT NCT07507838

    Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules

    Not yet reported Vigonvita Life Sciences 24 participants Est. completion 2026-12-31 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Recruiting NCT NCT07526519

    A Safety and Pharmacokinetics Study of TL-003 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis

    Not yet reported TrueLab Biopharmaceutical Co., Ltd 48 participants Est. completion 2027-04 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT00000669

    A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 25 participants 5 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00000773

    Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 1996-09 6 sites
    Other conditions: Pneumonia, Pneumocystis Carinii, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000988

    A Study of BMY-27857 in Patients With AIDS or AIDS Related Complex

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 40 participants 2 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00002251

    A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir

    Not yet reported Hoffmann-La Roche 20 participants 2 sites
    Other conditions: Cytomegalovirus Infections, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002370

    Study of Itraconazole in Patients With Advanced HIV Infection

    Not yet reported Janssen, LP 36 participants 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00003411

    Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer

    Not yet reported University of Pittsburgh Est. completion 2002-06 3 sites
    Other conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00003703

    Chemotherapy in Treating Patients With Advanced Solid Tumors

    Not yet reported Jewish General Hospital Est. completion 2004-03 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Withdrawn NCT NCT00003979

    CHS 828 in Treating Patients With Solid Tumors

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 28 sites
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Suspended NCT NCT00003980

    BIBX 1382 in Treating Patients With Solid Tumors

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 80 participants 27 sites
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00047762

    Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer

    Not yet reported Genentech, Inc. 3 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00084734

    Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors

    Not yet reported Roswell Park Cancer Institute 61 participants Est. completion 2009-12 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Terminated NCT NCT00113971

    Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)

    Not yet reported UCB Pharma 20 participants Est. completion 2007-06 3 sites
    Other conditions: Lupus Erythematosus, Systemic
    View official trial listing →
  • Completed NCT NCT00129337

    Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies

    Not yet reported Peregrine Pharmaceuticals 28 participants Est. completion 2009-08 6 sites
    Other conditions: Tumors
    View official trial listing →
  • Completed NCT NCT00244244

    A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

    Not yet reported CytRx 80 participants Est. completion 2007-01 10 sites
    Other conditions: Amyotrophic Lateral Sclerosis (ALS)
    View official trial listing →
  • Completed NCT NCT00244621

    Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age

    Not yet reported AstraZeneca 95 participants Est. completion 2008-08 38 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00255502

    307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects

    Not yet reported AstraZeneca 100 participants 31 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00294892

    Pharmacokinetics Study on Nevirapine Resistance in Tanzania

    Not yet reported Radboud University Medical Center 144 participants Est. completion 2010-06 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00329212

    The Pharmacokinetics Study of Concentrated Herbal Formula and Traditional Herbal Decoctions in Humans

    Committee on Chinese Medicine and Pharmacy 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00346229

    Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer

    Not yet reported Duke University 29 participants Est. completion 2011-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00380744

    A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis

    Not yet reported, Not yet reported Eli Lilly and Company 121 participants Est. completion 2007-11 14 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT00411931

    A Pharmacokinetics Study of MultiHance in Pediatric Patients

    Not yet reported Bracco Diagnostics, Inc 15 participants Est. completion 2007-12 1 site
    Other conditions: Central Nervous System Pathology
    View official trial listing →
  • Completed NCT NCT00424164

    Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 20 participants Est. completion 2010-05-28 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00431171

    Safety and Pharmacokinetics Study of Oral Lithium in Patients With Chronic Spinal Cord Injury

    Not yet reported The University of Hong Kong 20 participants Est. completion 2010-01 1 site
    Other conditions: Spinal Cord Injuries
    View official trial listing →
  • Completed NCT NCT00446004

    Effect of a Proton Pump Inhibitor on Gleevec® in Healthy Volunteers

    Not yet reported University of Pittsburgh 15 participants Est. completion 2009-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00446316

    Effect of Antacids on Gleevec® in Healthy Volunteers

    Not yet reported University of Pittsburgh 12 participants Est. completion 2008-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00459719

    A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation

    Not yet reported Astellas Pharma Inc 42 participants Est. completion 2009-03 5 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00481819

    A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation

    Not yet reported Astellas Pharma Inc 240 participants Est. completion 2009-03 9 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00508768

    A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis

    Not yet reported Scios, Inc. 16 participants Est. completion 2002-12
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00513214

    Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus

    Not yet reported, Not yet reported XOMA (US) LLC 68 participants Est. completion 2010-02 4 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00513994

    MQX-503 vs Nitroglycerin Ointment: A Pharmacokinetic Comparison in Normal Subjects

    Not yet reported MediQuest Therapeutics 6 participants Est. completion 2007-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00542217

    Phase Ia Dose-Escalation Safety, Pharmacodynamic and Pharmacokinetic Study of Imprime PGG™ Injection

    Not yet reported HiberCell, Inc. 24 participants Est. completion 2006-04
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00542464

    Multiple-Dose, Dose-Escalation Safety, Pharmacodynamics, and Pharmacokinetics Study of Imprime PGG™ Injection

    Not yet reported HiberCell, Inc. 12 participants Est. completion 2006-09
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00592124

    Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 168 participants Est. completion 2010-07 7 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00599404

    PK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400

    Not yet reported POZEN 18 participants Est. completion 2008-02
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00600535

    A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer

    Not yet reported Cougar Biotechnology, Inc. 31 participants Est. completion 2012-03 3 sites
    Other conditions: Prostate Neoplasms
    View official trial listing →
  • Completed NCT NCT00606515

    Pharmacokinetics Study of Liposomal Paclitaxel in Humans

    Not yet reported Shandong Luye Pharmaceutical Co., Ltd. 16 participants Est. completion 2008-10 2 sites
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT00614991

    An Interaction Study to Assess Drug Levels in Healthy Adult Subjects

    Not yet reported Garden State Infectious Disease Associates, PA 44 participants Est. completion 2008-03
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00619398

    A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients

    Not yet reported Astellas Pharma Inc 172 participants Est. completion 2009-03 6 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00628433

    Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis

    Not yet reported, Not yet reported Harbor Therapeutics 27 participants Est. completion 2009-05 10 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00631878

    Safety and Pharmacokinetics Study in VLBW Neonates With BSYX-A110

    Not yet reported, Not yet reported Biosynexus Incorporated 53 participants Est. completion 2003-08 1 site
    Other conditions: Neonatal Staphylococcal Sepsis
    View official trial listing →
  • Completed NCT NCT00636285

    Safety and Pharmacokinetics Study in Adults for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants

    Not yet reported Biosynexus Incorporated 8 participants Est. completion 2001-11 1 site
    Other conditions: Staphylococcal Sepsis
    View official trial listing →
  • Completed NCT NCT00668044

    Ciprofloxacin on Burned Patients

    Not yet reported Bayer 18 participants Est. completion 2003-11 7 sites
    Other conditions: Burns, Bacterial Infections
    View official trial listing →
  • Completed NCT NCT00676156

    A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis

    Not yet reported Oregon Health and Science University 40 participants Est. completion 2008-11 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00699387

    Population Pharmacokinetics of Benznidazole in Children With Chagas Disease

    Not yet reported Hospital de Niños R. Gutierrez de Buenos Aires 37 participants Est. completion 2011-05 1 site
    Other conditions: Chagas Disease
    View official trial listing →
  • Completed NCT NCT00732784

    Effect of Calcium on Gleevec Pharmacokinetics (PK) in Healthy Volunteers

    Not yet reported Jan Beumer 11 participants Est. completion 2012-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00732888

    Effect of Calcium on Tasigna Pharmacokinetics (PK) in Healthy Volunteers

    Not yet reported Jan Beumer 14 participants Est. completion 2011-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00749190

    BI 10773 add-on to Metformin in Patients With Type 2 Diabetes

    Not yet reported Boehringer Ingelheim 495 participants 116 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00761722

    Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma

    Not yet reported Celgene 31 participants Est. completion 2016-04-07 11 sites
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Lymphoma, Multiple Myeloma, Leukemia, Myelomonocytic, Chronic
    View official trial listing →
  • Completed NCT NCT00764465

    An Interaction Study to Assess Drug Levels in Healthy Adult Subjects

    Not yet reported Garden State Infectious Disease Associates, PA 45 participants Est. completion 2008-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00774800

    Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus

    Not yet reported Halozyme Therapeutics 22 participants Est. completion 2009-03 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Suspended NCT NCT00777816

    Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis

    Not yet reported XOMA (US) LLC 18 participants 2 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00785668

    A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects

    Not yet reported Aerovance, Inc. 10 participants Est. completion 2008-02 1 site
    Other conditions: Asthma
    View official trial listing →
  • Terminated NCT NCT00785772

    A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1 participants Est. completion 2010-04 1 site
    Other conditions: Renal Impairment
    View official trial listing →
  • Completed NCT NCT00789035

    12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients

    Not yet reported Boehringer Ingelheim 408 participants 74 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00791817

    Study to Evaluate Potential Food Effects

    Not yet reported Procter and Gamble 10 participants Est. completion 2006-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00793000

    Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults

    Not yet reported Pfizer 80 participants Est. completion 2009-12 1 site
    Other conditions: Respiratory Tract Infections
    View official trial listing →
  • Completed NCT NCT00802074

    An Interaction Study to Assess Drug Levels in Fasting Healthy Adult Subjects

    Not yet reported Garden State Infectious Disease Associates, PA 45 participants Est. completion 2009-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00845650

    Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)

    Not yet reported, Not yet reported Emergent BioSolutions 129 participants Est. completion 2010-10 1 site
    Other conditions: Anthrax
    View official trial listing →
  • Completed NCT NCT00861601

    Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease

    Not yet reported GlaxoSmithKline 38 participants Est. completion 2009-08 10 sites
    Other conditions: Liver Diseases
    View official trial listing →
  • Completed NCT NCT00864786

    Multiple Dose Healthy Volunteer Safety Pharmacokinetics Study

    Not yet reported Pfizer 50 participants Est. completion 2009-03 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT00867516

    Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis

    Not yet reported CSL Behring 127 participants Est. completion 2009-12 26 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT00871949

    Safety, Tolerability And Pharmacokinetics Study Of Single Doses Of PNU-100480 In Healthy Adults

    Not yet reported Sequella, Inc. 19 participants Est. completion 2009-08 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00920998

    Effect of Food Intake on Pharmacokinetic Profiles of Z-338

    Not yet reported Astellas Pharma Inc 30 participants Est. completion 2009-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00924053

    Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes

    Not yet reported Theracos 24 participants Est. completion 2009-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00924742

    A Single-Dose Pharmacokinetics Study of Tapimycin Injection

    Not yet reported Tri-Service General Hospital (TSGH) 12 participants Est. completion 2009-05
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00940186

    Clinical Pharmacokinetics Study on Pikamilone

    Chinese Academy of Sciences 30 participants Est. completion 2009-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00969449

    Pharmacokinetics Study Comparing Naproxen Sodium Extended Release and Naprelan

    Not yet reported Bayer 28 participants Est. completion 2009-05 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00984425

    The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors

    Not yet reported Istituto Clinico Humanitas 30 participants Est. completion 2013-08 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT00989872

    Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunteers

    Not yet reported Enanta Pharmaceuticals, Inc 67 participants 1 site
    Other conditions: Skin and Soft Tissue Infections, Methicillin-resistant Staphylococcus Aureus
    View official trial listing →
  • Completed NCT NCT00990145

    Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers

    Not yet reported Enanta Pharmaceuticals, Inc 52 participants Est. completion 2009-09 1 site
    Other conditions: MRSA, SSTI
    View official trial listing →
  • Terminated NCT NCT00991016

    Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers

    Not yet reported Pfizer 61 participants Est. completion 2010-08 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Terminated NCT NCT00995605

    AMAP102 - Safety, Tolerability and Pharmacokinetics in Healthy Subjects

    Not yet reported AnaMar AB 40 participants Est. completion 2009-08 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01000467

    Pharmacokinetics Study for Probucol

    Not yet reported Korea Otsuka Pharmaceutical Co., Ltd. 30 participants Est. completion 2009-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01001221

    Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor

    Not yet reported, Not yet reported Sanofi 19 participants Est. completion 2011-10 4 sites
    Other conditions: Neoplasms, Malignant
    View official trial listing →
  • Completed NCT NCT01014650

    Single Ascending Dose Safety, Tolerability and Pharmacokinetics Study of GLYX-13 in Normal Volunteers

    Not yet reported Naurex, Inc, an affiliate of Allergan plc 53 participants Est. completion 2015-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01063556

    Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.

    Not yet reported Eisai Co., Ltd. 6 participants Est. completion 2010-03 1 site
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01075906

    Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients

    Not yet reported Mutual Pharmaceutical Company, Inc. 75 participants Est. completion 2011-12 10 sites
    Other conditions: Familial Mediterranean Fever
    View official trial listing →
  • Completed NCT NCT01083888

    ASP1517 Pharmacokinetics Study in Anemia Patients on Hemodialysis

    Not yet reported Astellas Pharma Inc 12 participants Est. completion 2010-06-07 1 site
    Other conditions: Anemia, Hemodialysis, Renal Impairment
    View official trial listing →
  • Completed NCT NCT01189279

    Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia

    Not yet reported Allergan 42 participants Est. completion 2011-02 1 site
    Other conditions: Alopecia, Alopecia, Androgenetic, Baldness
    View official trial listing →
  • Completed NCT NCT01193595

    Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors

    Not yet reported Sanofi 39 participants Est. completion 2014-10 4 sites
    Other conditions: Neoplasms, Malignant
    View official trial listing →
  • Completed NCT NCT01202695

    Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)

    Not yet reported Emergent BioSolutions 50 participants Est. completion 2011-06 1 site
    Other conditions: Anthrax
    View official trial listing →
  • Completed NCT NCT01246791

    Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers

    Not yet reported Nobelpharma 12 participants Est. completion 2011-05
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01257178

    A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic Impairment

    Not yet reported Eli Lilly and Company Est. completion 2010-11 4 sites
    Other conditions: Insomnia
    View official trial listing →
  • Completed NCT NCT01279915

    A Safety and Pharmacokinetics Study of ASP0456 in Healthy Subjects

    Not yet reported Astellas Pharma Inc 32 participants Est. completion 2011-01 1 site
    Other conditions: Healthy, Pharmacokinetics of ASP0456
    View official trial listing →
  • Status unknown NCT NCT01299142

    Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6)

    Not yet reported Functional Genetics Inc. 48 participants Est. completion 2011-10 1 site
    Other conditions: Influenza
    View official trial listing →
  • Completed NCT NCT01317641

    Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer

    Not yet reported, Not yet reported Orion Corporation, Orion Pharma 136 participants Est. completion 2013-07 23 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01340846

    A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

    Not yet reported GlaxoSmithKline 48 participants Est. completion 2012-11-14 11 sites
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT01342042

    The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 36 participants Est. completion 2011-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01359462

    Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis

    Not yet reported Otsuka Beijing Research Institute 11 participants Est. completion 2010-01 1 site
    Other conditions: Hepatic Cirrhosis, Ascites
    View official trial listing →
  • Completed NCT NCT01365624

    Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects

    Not yet reported American Regent, Inc. 30 participants Est. completion 2008-07 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT01366339

    Tolerance and Pharmacokinetics Study of MNTX Tablets

    Not yet reported Bausch Health Americas, Inc. 37 participants Est. completion 2003-12 1 site
    Other conditions: Normal Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01378364

    Phase I Study of AbGn-168H in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 48 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01396239

    Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients

    Not yet reported Sarepta Therapeutics, Inc. 12 participants Est. completion 2012-06 1 site
    Other conditions: Duchenne Muscular Dystrophy
    View official trial listing →
  • Completed NCT NCT01404598

    Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male

    Not yet reported NicOx 24 participants Est. completion 2010-02
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Withdrawn NCT NCT01425320

    Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne

    Not yet reported Allergan Est. completion 2013-06
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT01435915

    Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects

    Not yet reported GlaxoSmithKline 24 participants Est. completion 2010-08-05 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT01437059

    Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C)

    Not yet reported Alnylam Pharmaceuticals 32 participants Est. completion 2012-09 2 sites
    Other conditions: Elevated LDL-Cholesterol (LDL-C)
    View official trial listing →
  • Completed NCT NCT01449747

    Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus

    Not yet reported The Catholic University of Korea 24 participants Est. completion 2015-07 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01454076

    Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma

    Not yet reported Millennium Pharmaceuticals, Inc. 112 participants Est. completion 2016-06-16 1 site
    Other conditions: Nonhematologic Malignancies, Lymphoma
    View official trial listing →
  • Completed NCT NCT01458743

    Ceftaroline China Pharmacokinetics Study

    Not yet reported Pfizer 24 participants Est. completion 2012-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01462318

    An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis

    Not yet reported Biogen 133 participants Est. completion 2016-01 19 sites
    Other conditions: Relapsing-Remitting Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01464450

    Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants

    Not yet reported Janssen Scientific Affairs, LLC 55 participants Est. completion 2011-12 1 site
    Other conditions: Pharmacokinetics, Bioavailability, Healthy Participants
    View official trial listing →
  • Completed NCT NCT01475981

    Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects

    Not yet reported Akros Pharma Inc. 70 participants Est. completion 2010-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01484431

    A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension

    Not yet reported, Not yet reported Eli Lilly and Company 20 participants Est. completion 2019-04-03 16 sites
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT01496261

    Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial

    Not yet reported Chong Kun Dang Pharmaceutical 60 participants Est. completion 2011-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01499498

    The Boceprevir and Sildenafil Pharmacokinetics Study

    Not yet reported Imperial College London 13 participants Est. completion 2014-05 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01532518

    Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance

    Not yet reported Menarini Group 27 participants Est. completion 2012-07 5 sites
    Other conditions: Colic
    View official trial listing →
  • Completed NCT NCT01542619

    A Safety and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor VIIa With Albumin (rVIIa-FP) in Healthy Male Volunteers

    Not yet reported CSL Behring 40 participants Est. completion 2012-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01546051

    A Study of BCI-838 and Several BCI-632 Prodrugs in Healthy Volunteers

    Not yet reported BrainCells Inc. 31 participants Est. completion 2012-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01548703

    A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers

    Not yet reported BrainCells Inc. 30 participants Est. completion 2012-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01549236

    Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease

    Not yet reported Drugs for Neglected Diseases 80 participants Est. completion 2012-10 3 sites
    Other conditions: Chagas' Disease
    View official trial listing →
  • Completed NCT NCT01557257

    Pharmacokinetics Study of ALO-02 and OxyContin

    Not yet reported Pfizer 13 participants Est. completion 2012-05 1 site
    Other conditions: Management of Moderate to Severe Pain
    View official trial listing →
  • Completed NCT NCT01559077

    Trial to Evaluate Safety, Tolerability, and Parmacokinetics of ALN-TTR02 in Healthy Volunteer Subjects

    Not yet reported Alnylam Pharmaceuticals 17 participants Est. completion 2012-11 2 sites
    Other conditions: TTR-mediated Amyloidosis
    View official trial listing →
  • Completed NCT NCT01559545

    A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis

    Not yet reported Dr. Reddy's Laboratories Limited 60 participants Est. completion 2013-03 12 sites
    Other conditions: Clostridium Difficile Associated Diarrhea
    View official trial listing →
  • Completed NCT NCT01565746

    Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese Patients

    Not yet reported Bayer 19 participants Est. completion 2016-04 3 sites
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT01606163

    Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection

    Not yet reported Green Cross Corporation 36 participants Est. completion 2013-12 1 site
    Other conditions: Hepatitis B
    View official trial listing →
  • Completed NCT NCT01618877

    A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy Volunteers

    Not yet reported UCB Pharma 24 participants Est. completion 2012-07 1 site
    Other conditions: Human Volunteers
    View official trial listing →
  • Completed NCT NCT01620060

    Lurasidone Pediatric Pharmacokinetics Study

    Not yet reported Sumitomo Pharma America, Inc. 105 participants Est. completion 2013-05 10 sites
    Other conditions: Schizophrenia, Autism
    View official trial listing →
  • Completed NCT NCT01649427

    Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 73 participants Est. completion 2015-08-20 5 sites
    Other conditions: Pharmacokinetics Study in de Novo Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01662531

    A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B

    Not yet reported CSL Behring 27 participants 17 sites
    Other conditions: Hemophilia B
    View official trial listing →
  • Completed NCT NCT01663038

    Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination

    Not yet reported Chong Kun Dang Pharmaceutical 60 participants Est. completion 2011-09 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01666691

    An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects

    Not yet reported Zafgen, Inc. 160 participants Est. completion 2013-05 3 sites
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01684605

    Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers

    Not yet reported Chong Kun Dang Pharmaceutical 31 participants Est. completion 2013-01-03 1 site
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT01684891

    A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers

    Not yet reported Hoffmann-La Roche 6 participants Est. completion 2012-10 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01685671

    Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers

    Not yet reported Chong Kun Dang Pharmaceutical 34 participants Est. completion 2013-01-15 1 site
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT01700335

    Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)

    Not yet reported SymBio Pharmaceuticals 9 participants Est. completion 2015-02 3 sites
    Other conditions: Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01701739

    A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy Volunteers

    Not yet reported Hoffmann-La Roche 28 participants Est. completion 2013-01 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01704001

    Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment

    Not yet reported Asahi Kasei Therapeutics Corporation 40 participants Est. completion 2014-06 1 site
    Other conditions: Disseminated Intravascular Coagulation
    View official trial listing →
  • Completed NCT NCT01711762

    A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers

    Not yet reported Genentech, Inc. 6 participants Est. completion 2012-09 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01733992

    A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease

    Not yet reported Rigel Pharmaceuticals 36 participants Est. completion 2013-02 1 site
    Other conditions: Keratoconjunctivitis Sicca
    View official trial listing →
  • Completed NCT NCT01737866

    Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency

    Not yet reported Cytokinetics 13 participants Est. completion 2013-05 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT01751568

    Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 40 participants Est. completion 2019-11-27 4 sites
    Other conditions: HIV Infections, Tuberculosis
    View official trial listing →
  • Completed NCT NCT01757860

    Safety and Pharmacokinetics Study of CARD-024 in Healthy Subjects

    Not yet reported Cardiavent Inc. 34 participants Est. completion 2012-01 1 site
    Other conditions: Drug Safety, Heart; Disease, Activity
    View official trial listing →
  • Withdrawn NCT NCT01765556

    A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma

    Not yet reported Hoffmann-La Roche Est. completion 2013-10
    Other conditions: Malignant Melanoma, Neoplasms
    View official trial listing →
  • Completed NCT NCT01765569

    A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma

    Not yet reported Hoffmann-La Roche 29 participants Est. completion 2014-06 13 sites
    Other conditions: Malignant Melanoma, Neoplasms
    View official trial listing →
  • Withdrawn NCT NCT01787578

    Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)

    Not yet reported Thomas S. Scanlan Est. completion 2014-02 1 site
    Other conditions: X-Linked Adrenoleukodystrophy, Adrenomyeloneuropathy
    View official trial listing →
  • Completed NCT NCT01806311

    Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg

    Not yet reported HanAll BioPharma Co., Ltd. 36 participants Est. completion 2013-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01812642

    A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 33 participants Est. completion 2008-12 6 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01818921

    An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome

    Not yet reported Zafgen, Inc. 17 participants Est. completion 2013-11 1 site
    Other conditions: Obesity, Over-weight, Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT01821872

    Paracetamol CSF Pharmacokinetics Study

    Not yet reported Barts & The London NHS Trust 30 participants Est. completion 2011-11 1 site
    Other conditions: Paracetamol
    View official trial listing →
  • Completed NCT NCT01830816

    Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment

    Not yet reported Millennium Pharmaceuticals, Inc. 41 participants Est. completion 2016-11-18 11 sites
    Other conditions: Multiple Myeloma, Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT01844804

    A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01)

    Not yet reported Pfizer 146 participants Est. completion 2013-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01857583

    Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs

    Not yet reported Daiichi Sankyo Co., Ltd. 80 participants Est. completion 2012-12 1 site
    Other conditions: Venous Thromboembolism
    View official trial listing →
  • Completed NCT NCT01857622

    Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment

    Not yet reported Daiichi Sankyo Co., Ltd. 93 participants Est. completion 2013-01 1 site
    Other conditions: Non-valvular Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01870999

    A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 41 participants Est. completion 2008-10 7 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01883505

    A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease Patients

    Not yet reported NeuroDerm Ltd. 30 participants Est. completion 2015-04-26 3 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01897038

    A Safety, Tolerability, and Pharmacokinetics Study of Onartuzumab as Single Agent or in Combination With Sorafenib in Participants With Advanced Hepatocellular Carcinoma

    Not yet reported Hoffmann-La Roche 9 participants Est. completion 2015-03 10 sites
    Other conditions: Carcinoma, Hepatocellular
    View official trial listing →
  • Completed NCT NCT01917760

    Pharmacokinetics Study of Gamma-aminobutyric Acid

    Huashan Hospital 12 participants Est. completion 2014-12 1 site
    Other conditions: Diabetes Mellitus, Diabetes Mellitus, Type 1, Glucose Metabolism Disorders, Metabolic Diseases, Endocrine System Diseases, Autoimmune Diseases, Immune System Diseases
    View official trial listing →
  • Completed NCT NCT01918735

    A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects

    Not yet reported Jazz Pharmaceuticals 66 participants Est. completion 2013-12 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT01925859

    EryDex Pharmacokinetics in Healthy Volunteers

    Not yet reported Quince Therapeutics S.p.A. 18 participants Est. completion 2013-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01926652

    Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg

    Not yet reported Shin Poong Pharmaceutical Co. Ltd. 34 participants Est. completion 2013-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01931189

    Pharmacokinetics Study of NI-071

    Not yet reported Nichi-Iko Pharmaceutical Co., Ltd. 96 participants Est. completion 2014-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01931436

    Pharmacokinetics Study of Qing'E Pill

    Not yet reported Shanghai University of Traditional Chinese Medicine 24 participants Est. completion 2014-04 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT01960114

    Study of Long-Acting Acetaminophen in Postoperative Dental Pain

    Not yet reported McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. 403 participants Est. completion 2014-04 1 site
    Other conditions: Dental Pain
    View official trial listing →
  • Status unknown NCT NCT01985152

    A Phase Ⅰa Study of Azilsartan Trimethylethanolamine in Healthy Volunteers

    Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 62 participants 1 site
    Other conditions: Health
    View official trial listing →
  • Completed NCT NCT02000414

    Pharmacokinetics Study of Intraperitoneal Administration of Daptomycin in Peritoneal Infection

    Not yet reported University Hospital, Caen 8 participants Est. completion 2017-12 1 site
    Other conditions: Peritoneal Infection
    View official trial listing →
  • Completed NCT NCT02004691

    Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

    Not yet reported, Not yet reported Genzyme, a Sanofi Company 36 participants Est. completion 2023-10-19 24 sites
    Other conditions: Sphingomyelin Lipidosis
    View official trial listing →
  • Completed NCT NCT02008279

    A Safety and Pharmacokinetics Study of CNTO 3157 in Healthy Japanese and Caucasian Participants

    Not yet reported Janssen Research & Development, LLC 40 participants Est. completion 2014-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02010333

    A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation

    Not yet reported Dr. Reddy's Laboratories Limited 22 participants Est. completion 2014-08 2 sites
    Other conditions: Head Lice Infestation
    View official trial listing →
  • Completed NCT NCT02010632

    Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products

    Not yet reported Khon Kaen University 32 participants Est. completion 2014-12 1 site
    Other conditions: Pharmacodynamics
    View official trial listing →
  • Completed NCT NCT02014051

    Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)

    Not yet reported SymBio Pharmaceuticals 10 participants Est. completion 2014-11 4 sites
    Other conditions: Myelodysplastic Syndrome
    View official trial listing →
  • Terminated NCT NCT02014649

    Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza

    Not yet reported, Not yet reported Biota Scientific Management Pty Ltd 15 participants Est. completion 2014-05 28 sites
    Other conditions: Influenza
    View official trial listing →
  • Completed NCT NCT02028286

    A 21 Day Pharmacokinetics Study in Papulopustular Rosacea

    Not yet reported Maruho Co., Ltd. 25 participants 2 sites
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT02035605

    A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients

    Not yet reported Sanofi 51 participants Est. completion 2017-07-20 14 sites
    Other conditions: Hemophilia A, Hemophilia B
    View official trial listing →
  • Completed NCT NCT02045524

    A Pilot Single Dose Crossover Pharmacokinetics Study Of JDP-205 Injection, 10 mg, In Healthy Male And Female Volunteers

    Not yet reported JDP Therapeutics, Inc. 4 participants Est. completion 2011-09 1 site
    Other conditions: Acute Urticaria
    View official trial listing →
  • Completed NCT NCT02047344

    Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC

    Not yet reported Golden Biotechnology Corporation 31 participants Est. completion 2018-12-07 10 sites
    Other conditions: Non-small Cell Lung Cancer Stage IV
    View official trial listing →
  • Terminated NCT NCT02047656

    To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension

    Not yet reported Novartis Pharmaceuticals 93 participants Est. completion 2014-08 1 site
    Other conditions: Part 1 - Healthy Volunteers, Part 2 - Patients With Hypertension
    View official trial listing →
  • Completed NCT NCT02053454

    A Study of the Safety, Tolerability and Pharmacokinetics of ALN-TTR02 in Japanese Healthy Volunteers

    Not yet reported Alnylam Pharmaceuticals 12 participants Est. completion 2014-06 1 site
    Other conditions: Transthyretin (TTR)-Mediated Amyloidosis
    View official trial listing →
  • Completed NCT NCT02055300

    Safety, Tolerability and Pharmacokinetics Study of LY03005

    Not yet reported Luye Pharma Group Ltd. 88 participants Est. completion 2014-08 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT02063295

    An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury

    Not yet reported Zafgen, Inc. 14 participants Est. completion 2014-11 4 sites
    Other conditions: Obesity, Over-weight, Hypothalamic Injury, Craniopharyngioma
    View official trial listing →
  • Status unknown NCT NCT02064777

    Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver Transplantation

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 60 participants Est. completion 2014-09 1 site
    Other conditions: Pediatric Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02079545

    Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants

    Not yet reported Janssen Research & Development, LLC 144 participants Est. completion 2015-01 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02087579

    Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

    Not yet reported Janssen Research & Development, LLC 305 participants Est. completion 2014-12 24 sites
    Other conditions: Psychotic Disorders, Schizophrenia, Bipolar Disorder, Depressive Disorder
    View official trial listing →
  • Completed NCT NCT02122809

    Phase I Study of Chiauranib in Patients With Advanced Solid Tumors

    Not yet reported Chipscreen Biosciences, Ltd. 18 participants Est. completion 2016-06 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT02138136

    Lubiprostone for Children With Constipation

    Not yet reported Sucampo Pharma Americas, LLC 419 participants Est. completion 2017-05-01 85 sites
    Other conditions: Constipation - Functional
    View official trial listing →
  • Completed NCT NCT02163707

    UW Psilocybin Pharmacokinetics Study

    Not yet reported University of Wisconsin, Madison 12 participants Est. completion 2015-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02165033

    Multiple-dose Pharmacokinetics Study of "SYN006 HFA MDI" Administered Orally to Healthy Volunteers

    Not yet reported Intech Biopharm Ltd. 16 participants Est. completion 2013-02 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT02171572

    Single and Multiple Oral Doses of Dabigatran Etexilate in Healthy Chinese Subjects

    Not yet reported Boehringer Ingelheim 28 participants
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02172131

    Safety, Tolerability and Pharmacokinetics Study of BI 1744 CL in Healthy Male Subjects

    Not yet reported Boehringer Ingelheim 64 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02180269

    A Safety, Tolerability and Pharmacokinetics Study of JNJ-54861911 in Healthy Japanese Male Participants

    Not yet reported Janssen Pharmaceutical K.K. 24 participants Est. completion 2014-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02187497

    Pharmacokinetics of BIBR 277 in Hypertensive Patients

    Not yet reported Boehringer Ingelheim 93 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02194322

    Safety, Tolerability and Pharmacokinetics After Administration of Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 38 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02194335

    Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIBN 4096 BS in Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 32 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02194777

    Safety, Tolerability and Pharmacokinetics of Inhalative Administration of BIBN 4096 BS in Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 48 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02197975

    Randomized, Crossover Safety and Pharmacokinetics Study of PT010

    Not yet reported Pearl Therapeutics, Inc. 20 participants Est. completion 2014-10 1 site
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT02201238

    Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium

    Not yet reported GlaxoSmithKline 18 participants Est. completion 2014-11-21 1 site
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT02210247

    Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers

    Not yet reported Pacira Pharmaceuticals, Inc 60 participants Est. completion 2014-09 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02239081

    A Safety and Tolerability Study of CTP-730 in Healthy Volunteers

    Not yet reported Concert Pharmaceuticals 55 participants Est. completion 2015-05 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02254538

    A Safety, Tolerability and Preliminary Pharmacokinetics of BILR 355 BS Single-rising Dose Study in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 54 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02262728

    An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease

    Not yet reported Janssen Research & Development, LLC 40 participants Est. completion 2018-04-25 1 site
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT02280018

    A Safety, Tolerability and Pharmacokinetics Study of a Single Intravenous Dose of JNJ-49122944 in Healthy Male Participants

    Not yet reported Janssen Research & Development, LLC 12 participants Est. completion 2014-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02288208

    Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B

    Not yet reported TetraLogic Pharmaceuticals 7 participants Est. completion 2015-05 3 sites
    Other conditions: Hepatitis B
    View official trial listing →
  • Completed NCT NCT02295813

    Safety and Pharmacokinetics Study of FBF001

    Not yet reported Fab'entech 16 participants
    Other conditions: Avian Influenza
    View official trial listing →
  • Completed NCT NCT02310906

    Phase I/II Study of SRP-4053 in DMD Patients

    Not yet reported, Not yet reported Sarepta Therapeutics, Inc. 39 participants Est. completion 2019-03-25 5 sites
    Other conditions: Duchenne Muscular Dystrophy
    View official trial listing →
  • Completed NCT NCT02319941

    Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes

    Not yet reported Seung-Jung Park 65 participants Est. completion 2017-03-10 1 site
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT02348177

    Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

    Not yet reported Drugs for Neglected Diseases 96 participants Est. completion 2016-12 5 sites
    Other conditions: Acquired Immunodeficiency Syndrome, Tuberculosis
    View official trial listing →
  • Completed NCT NCT02354937

    Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal Impairment

    Not yet reported ViiV Healthcare 16 participants Est. completion 2016-11-01 2 sites
    Other conditions: Infection, Human Immunodeficiency Virus, HIV Infections
    View official trial listing →
  • Completed NCT NCT02356302

    Safety and Pharmacokinetics of Intravaginal Rings Containing Vicriviroc (MK-4176) and/or MK-2048

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2016-03 2 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Status unknown NCT NCT02395068

    Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors

    Not yet reported Biotech Pharmaceutical Co., Ltd. 40 participants Est. completion 2015-12 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Withdrawn NCT NCT02397395

    An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.

    Not yet reported Janssen R&D Ireland Est. completion 2016-05 6 sites
    Other conditions: Renal Impairment, End-stage Renal Disease
    View official trial listing →
  • Completed NCT NCT02404259

    PK TDF in Thai HIV-infected Children

    Not yet reported The HIV Netherlands Australia Thailand Research Collaboration 32 participants Est. completion 2012-05 1 site
    Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT02412722

    A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic Malignancies

    Not yet reported Millennium Pharmaceuticals, Inc. 61 participants Est. completion 2018-05-31 5 sites
    Other conditions: Non-hematologic Malignancy
    View official trial listing →
  • Completed NCT NCT02421172

    Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients

    Not yet reported Novartis Pharmaceuticals 66 participants Est. completion 2016-11-23 16 sites
    Other conditions: Hidradenitis Suppurativa (Acne Inversa)
    View official trial listing →
  • Terminated NCT NCT02447458

    MLN3126 Single Rising Dose Study

    Not yet reported Takeda 39 participants Est. completion 2014-02 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02456584

    Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods

    Not yet reported FHI 360 42 participants Est. completion 2018-08-30 2 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT02464488

    New Oral Direct Anticoagulants in Patients 80 Years Old and Over : a Population Pharmacokinetics Study

    Hôpital Charles Foix 232 participants Est. completion 2021-08-25 2 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT02467790

    Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function

    Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 24 participants Est. completion 2016-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02492776

    A Multiple-Dose Pharmacokinetics Study of Two Gefapixant (AF-219/MK-7264) Formulations

    Not yet reported Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 14 participants Est. completion 2015-08-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02499146

    Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer

    Not yet reported Pfizer 26 participants Est. completion 2024-12-24 7 sites
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT02499224

    Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy

    Not yet reported CellabMED 39 participants Est. completion 2018-07-04 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT02527265

    Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

    Not yet reported Mannkind Corporation 30 participants Est. completion 2020-06-25 13 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02530905

    Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients

    Not yet reported Sarepta Therapeutics, Inc. 12 participants Est. completion 2018-10-03 3 sites
    Other conditions: Duchenne Muscular Dystrophy
    View official trial listing →
  • Completed NCT NCT02534753

    A Pharmacokinetics Study of Intravenous Ascorbic Acid

    Not yet reported McGuff Pharmaceuticals, Inc. 8 participants Est. completion 2016-01 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT02558413

    Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy Volunteers

    Not yet reported Biota Pharmaceuticals, Inc. 60 participants Est. completion 2015-12 1 site
    Other conditions: Pharmacokinetics, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02586194

    Pharmacokinetics Study in Patients With Impaired Hepatic Function

    Not yet reported Astellas Pharma Inc 24 participants Est. completion 2016-09-27 6 sites
    Other conditions: Patients With Impaired Hepatic Function
    View official trial listing →
  • Status unknown NCT NCT02587273

    The Pharmacokinetics of Fentanyl in Intensive Care Patients

    Not yet reported Oslo University Hospital 150 participants Est. completion 2017-11 1 site
    Other conditions: Multiple Organ Failure, Critical Care, Intensive Care
    View official trial listing →
  • Completed NCT NCT02603497

    Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function

    Not yet reported Astellas Pharma Inc 31 participants Est. completion 2016-12-19 2 sites
    Other conditions: Patients With Impaired Renal Function
    View official trial listing →
  • Completed NCT NCT02604498

    Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Moderate Impaired Hepatic Function

    Not yet reported Zhejiang Medicine Co., Ltd. 20 participants Est. completion 2018-01-15 1 site
    Other conditions: Liver Dysfunction
    View official trial listing →
  • Completed NCT NCT02605590

    Safety, Tolerability and Pharmacokinetics Study of AIR DNAse Administered by Inhalation to Healthy Adult Volunteers

    Not yet reported Protalix 18 participants Est. completion 2016-02 1 site
    Other conditions: Cystic Fibrosis (CF)
    View official trial listing →
  • Completed NCT NCT02629224

    ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis

    Not yet reported Astellas Pharma Inc 18 participants Est. completion 2008-10 2 sites
    Other conditions: Patients With Impaired Renal Function and Haemodialysis
    View official trial listing →
  • Completed NCT NCT02652936

    A Pharmacokinetics Study of AF-130 in Healthy Subjects

    Not yet reported Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 80 participants Est. completion 2016-03 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02668367

    Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers

    Not yet reported Biota Pharmaceuticals, Inc. 36 participants Est. completion 2016-02 1 site
    Other conditions: Pharmacokinetics, Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT02671513

    A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 30 participants Est. completion 2017-04 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT02684266

    A Study of SHR6390 in Advanced Solid Tumor Patients

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 40 participants Est. completion 2019-06-28 1 site
    Other conditions: Neoplasm
    View official trial listing →
  • Terminated NCT NCT02686281

    Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes

    Not yet reported Genmedica Therapeutics S.L. 19 participants Est. completion 2014-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02698475

    An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age

    Not yet reported Janssen Research & Development, LLC 44 participants Est. completion 2020-10 31 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02710526

    Phase II Pharmacokinetics Study of CAM2038

    Not yet reported Braeburn Pharmaceuticals 66 participants Est. completion 2017-07-03 3 sites
    Substance use disorder Other conditions: Chronic Pain
    View official trial listing →
  • Completed NCT NCT02724423

    Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects

    Not yet reported Neurelis, Inc. 57 participants Est. completion 2019-09-10 4 sites
    Other conditions: Acute Repetitive Seizures
    View official trial listing →
  • Completed NCT NCT02735122

    Study of Acetaminophen (ACM) in Post-operative Dental Pain

    Not yet reported Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 420 participants Est. completion 2016-10-05 1 site
    Other conditions: Post Operative Dental Pain
    View official trial listing →
  • Completed NCT NCT02741947

    Levodopa Benserazide Generic Formulation Versus the Originator

    Not yet reported IRCCS San Raffaele Roma 44 participants Est. completion 2015-12 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT02748694

    Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study

    Not yet reported Neurocrine Biosciences 114 participants Est. completion 2019-09-22 1 site
    Other conditions: Healthy Volunteers, Schizophrenia
    View official trial listing →
  • Completed NCT NCT02762643

    DP-R213 Pharmacokinetics Study

    Not yet reported Alvogen Korea 61 participants Est. completion 2016-08
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02767297

    Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis

    Not yet reported, Not yet reported Flatley Discovery Lab LLC 46 participants Est. completion 2016-10 1 site
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT02785601

    PK Study of Diet Effect of Trazodone Hydrochloride Prolonged-Released Tablets in Healthy Chinese

    Not yet reported Lee's Pharmaceutical Limited 15 participants Est. completion 2018-01-04 1 site
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT02785614

    PK Study of Multi-dose Trazodone Hydrochloride Prolonged-released Tablets in Healthy Chinese

    Not yet reported Lee's Pharmaceutical Limited 12 participants Est. completion 2018-01-04 1 site
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT02786043

    PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-doses

    Not yet reported Lee's Pharmaceutical Limited 12 participants Est. completion 2016-01
    Other conditions: Peripheral Arterial Diseases
    View official trial listing →
  • Completed NCT NCT02786069

    A Single-dose Escalation Safety and PK Study for PLC in Healthy Chinese

    Not yet reported Lee's Pharmaceutical Limited 16 participants Est. completion 2016-01
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT02786082

    Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy Volunteers

    Not yet reported Lee's Pharmaceutical Limited 29 participants Est. completion 2017-11-30
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02788188

    Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 38 participants Est. completion 2018-04-30 1 site
    Other conditions: Middle East Respiratory Syndrome Coronavirus
    View official trial listing →
  • Completed NCT NCT02790840

    A Multiple-Dose Pharmacokinetics Study of Three Gefapixant (AF-219/MK-7264) Formulations

    Not yet reported Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 32 participants Est. completion 2016-06-21 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02814058

    Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation

    Not yet reported Biolab Sanus Farmaceutica 28 participants Est. completion 2018-02-22 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02817750

    Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation

    Not yet reported Biolab Sanus Farmaceutica 28 participants Est. completion 2018-02-22 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02826044

    The Pharmacokinetics Study of Single and Multiple Dose of SP2086 in Healthy Volunteers

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 30 participants 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02840812

    Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function

    Not yet reported Zhejiang Medicine Co., Ltd. 24 participants Est. completion 2019-01 1 site
    Other conditions: Kidney Dysfunction
    View official trial listing →
  • Completed NCT NCT02924766

    A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)

    Not yet reported Janssen Research & Development, LLC 34 participants Est. completion 2019-07-19 6 sites
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Terminated NCT NCT02936492

    BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

    Not yet reported Bayer 32 participants Est. completion 2017-10-16 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02952547

    Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects

    Not yet reported Daewoong Pharmaceutical Co. LTD. 52 participants Est. completion 2017-01-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT02957435

    Pharmacokinetics Study of Eplerenone Coated Tablets

    Not yet reported Biolab Sanus Farmaceutica Est. completion 2017-12 1 site
    Other conditions: Pharmacokinetics, Healthy Subjects, Fasting
    View official trial listing →
  • Completed NCT NCT02962024

    Does Local Morphine Add to Local Anesthetics in Serratus Anterior Plane Block Has a System Analgesic Effect?

    Not yet reported Fatma Adel El sherif,MD 40 participants Est. completion 2018-10 1 site
    Other conditions: Postoperative Complications
    View official trial listing →
  • Completed NCT NCT02963324

    Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers

    Not yet reported University Hospital, Basel, Switzerland 12 participants Est. completion 2017-01 1 site
    Other conditions: Malaria
    View official trial listing →
  • Completed NCT NCT02990598

    Hydoxyurea Exposure in Lactation A Pharmacokinetics Study (HELPS)

    Children's Hospital Medical Center, Cincinnati 16 participants Est. completion 2018-06-19 1 site
    Other conditions: Sickle Cell Anemia
    View official trial listing →
  • Completed NCT NCT02993133

    Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid.

    Not yet reported University Hospital, Limoges 53 participants Est. completion 2019-04 3 sites
    Other conditions: Autoimmune Bullous Dermatose
    View official trial listing →
  • Completed NCT NCT02994407

    Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia A

    Not yet reported Novo Nordisk A/S 50 participants Est. completion 2018-10-15 19 sites
    Other conditions: Congenital Bleeding Disorder, Haemophilia A
    View official trial listing →
  • Completed NCT NCT03000439

    A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA

    Not yet reported Pfizer 100 participants Est. completion 2024-03-27 52 sites
    Other conditions: Arthritis Juvenile Idiopathic
    View official trial listing →
  • Completed NCT NCT03009474

    Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers

    Not yet reported HK inno.N Corporation 52 participants Est. completion 2015-04 1 site
    Other conditions: Hypertension, Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT03010267

    DP-R213 Phase 1 Pharmacokinetics Study

    Not yet reported Alvogen Korea 46 participants Est. completion 2017-03-29
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03013881

    A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers

    Not yet reported United BioPharma 18 participants Est. completion 2019-04-02 1 site
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Status unknown NCT NCT03016494

    Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects

    Not yet reported Daewoong Pharmaceutical Co. LTD. 56 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT03076905

    Pharmacokinetics of IV Formulation

    Not yet reported F2G Ltd Est. completion 2017-08
    Other conditions: Invasive Aspergillosis
    View official trial listing →
  • Completed NCT NCT03175497

    Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors

    Not yet reported Taizhou EOC Pharma Co., Ltd. 15 participants Est. completion 2018-08-15 1 site
    Other conditions: Solid Tumor, Adult
    View official trial listing →
  • Completed NCT NCT03205163

    A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)

    Not yet reported, Not yet reported Bioverativ, a Sanofi company 16 participants Est. completion 2018-11-12 10 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT03218995

    Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping

    Not yet reported Sarepta Therapeutics, Inc. 15 participants Est. completion 2021-03-10 4 sites
    Other conditions: Duchenne Muscular Dystrophy
    View official trial listing →
  • Completed NCT NCT03230916

    A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)

    Not yet reported Merck Sharp & Dohme LLC 47 participants Est. completion 2020-08-11 33 sites
    Other conditions: Suspected or Documented Gram-negative Bacterial Infection
    View official trial listing →
  • Completed NCT NCT03276988

    Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients

    Not yet reported, Not yet reported Genexine, Inc. 8 participants Est. completion 2020-01-20 5 sites
    Other conditions: Total Thyroidectomy, Near-total Thyroidectomy
    View official trial listing →
  • Completed NCT NCT03289208

    Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment

    Not yet reported Shionogi 30 participants Est. completion 2018-04-20 1 site
    Other conditions: Renal Impairment, Healthy
    View official trial listing →
  • Completed NCT NCT03289234

    Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment

    Not yet reported Shionogi 22 participants Est. completion 2018-07-24 2 sites
    Other conditions: Hepatic Impairment, Healthy
    View official trial listing →
  • Completed NCT NCT03289507

    Longvida Curcumin Human Pharmacokinetics Study

    Not yet reported Clinical Nutrition Research Center, Illinois Institute of Technology 9 participants Est. completion 2018-01-30 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03292406

    A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

    Not yet reported Galderma R&D 86 participants Est. completion 2020-03-17 21 sites
    Other conditions: Cutaneous T Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT03298672

    Safety, Tolerability, and Pharmacokinetics Study of NDX-1017

    Not yet reported LeonaBio 88 participants Est. completion 2019-09-05 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT03326986

    Safety, Tolerability and Pharmacokinetics Study of MK-7252 in Healthy Adult Participants (MK-7252-001)

    Not yet reported Merck Sharp & Dohme LLC 24 participants Est. completion 2018-12-17 1 site
    Other conditions: Pharmacokinetics, Cancer
    View official trial listing →
  • Completed NCT NCT03355196

    First-in-human, Safety, Tolerability and Pharmacokinetics Study of LRX712 in Osteoarthritic Patients

    Not yet reported Novartis Pharmaceuticals 42 participants Est. completion 2019-03-26 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT03361956

    An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection

    Not yet reported Janssen Sciences Ireland UC 232 participants Est. completion 2020-08-13 76 sites
    Other conditions: Hepatitis B
    View official trial listing →
  • Completed NCT NCT03394209

    A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza

    Not yet reported Capital Medical University 34 participants Est. completion 2019-03-27 1 site
    Other conditions: Influenza, Human, Critical Illness, Influenza
    View official trial listing →
  • Completed NCT NCT03428347

    An Open Study of the Safety and Pharmacokinetics of a Medicinal Product for Emergency Prevention of Ebola

    Not yet reported Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 25 participants Est. completion 2018-12-29 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03453177

    Intravenous and Oral Fosfomycin in Hospitalised Neonates With Clinical Sepsis

    Not yet reported Drugs for Neglected Diseases 120 participants Est. completion 2019-05-24 1 site
    Other conditions: Neonatal SEPSIS
    View official trial listing →
  • Completed NCT NCT03456648

    Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study

    Not yet reported Universitaire Ziekenhuizen KU Leuven 24 participants Est. completion 2018-08-24 1 site
    Other conditions: ESRD, Anticoagulant Toxicity
    View official trial listing →
  • Terminated NCT NCT03490162

    Safety and Pharmacokinetics Study of DM1157 to Treat Malaria

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 50 participants Est. completion 2019-09-06 1 site
    Other conditions: Malaria
    View official trial listing →
  • Completed NCT NCT03542916

    Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers

    Not yet reported HK inno.N Corporation 56 participants Est. completion 2015-12 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03565068

    A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007)

    Not yet reported Merck Sharp & Dohme LLC 75 participants Est. completion 2020-04-03 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT03565315

    Phase I Study to Evaluate a Human Monoclonal Antibody (MAb) 10E8VLS Administered Alone or Concurrently With MAb VRC07-523LS Via Subcutaneous Injection in Healthy Adults

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 9 participants Est. completion 2019-03-04 1 site
    Other conditions: Healthy Adult Immune Response
    View official trial listing →
  • Completed NCT NCT03605277

    Pharmacokinetics Study of Asciminib in Subjects With Impaired Renal Function Compared to Matched Healthy Volunteers

    Not yet reported Novartis Pharmaceuticals 14 participants Est. completion 2019-04-14 2 sites
    Other conditions: Renal Impairment
    View official trial listing →
  • Completed NCT NCT03611010

    Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients

    Not yet reported Cumberland Pharmaceuticals 40 participants Est. completion 2020-02-24 1 site
    Other conditions: Hypercholesterolemia, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03673696

    The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects

    Not yet reported Sunshine Lake Pharma Co., Ltd. 105 participants Est. completion 2019-07-05 1 site
    Other conditions: Chronic Hepatitis c
    View official trial listing →
  • Completed NCT NCT03692949

    A Study of LY3451838 in Healthy Participants

    Not yet reported Eli Lilly and Company 53 participants Est. completion 2020-02-26 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03698318

    Pharmacokinetics Assessing Bioavailability of Gingerols and Shogaols of Five Ginger Extracts

    Not yet reported Givaudan France Naturals 20 participants Est. completion 2018-12-07 1 site
    Other conditions: Healthy Subject
    View official trial listing →
  • Completed NCT NCT03698695

    A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers

    Not yet reported Theranexus 152 participants Est. completion 2019-12-20 7 sites
    Other conditions: Cognitive Impairment, Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT03709355

    Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs

    Not yet reported Viriom 56 participants Est. completion 2019-09-06 1 site
    Other conditions: HIV-1-infection
    View official trial listing →
  • Terminated NCT NCT03764774

    A Study of LY3463251 in Healthy Participants

    Not yet reported Eli Lilly and Company 118 participants Est. completion 2020-12-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03780907

    Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy

    Not yet reported Eisai Co., Ltd. 18 participants Est. completion 2003-08-06 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Terminated NCT NCT03803163

    A Safety, Tolerability and Pharmacokinetics Study of TransCon Treprostinil in Healthy Adult Male Volunteers

    Not yet reported Ascendis Pharma A/S 20 participants Est. completion 2015-06
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Terminated NCT NCT03804515

    A Mass Balance and Pharmacokinetics Study of 14C-Labeled Poziotinib in Cancer Patients Suitable for Treatment With Poziotinib

    Not yet reported Spectrum Pharmaceuticals, Inc 2 participants Est. completion 2020-06-17 1 site
    Other conditions: Solid Tumor
    View official trial listing →
  • Completed NCT NCT03811678

    The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects

    Not yet reported Sunshine Lake Pharma Co., Ltd. 120 participants Est. completion 2018-05-29 1 site
    Other conditions: Chronic Hepatitis c
    View official trial listing →
  • Completed NCT NCT03873324

    Safety and Pharmacokinetics Study of CPL500036 Compound in Healthy Volunteers

    Not yet reported Celon Pharma SA 56 participants Est. completion 2019-09-16 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03883776

    Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

    Not yet reported Universitaire Ziekenhuizen KU Leuven 12 participants Est. completion 2019-10-29 1 site Stand-alone
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Completed NCT NCT03886597

    Nutritional Intervention With Table Olives in Healthy Volunteers

    Not yet reported, Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 58 participants Est. completion 2019-06-15 1 site Stand-alone
    Other conditions: Healthy, Biological Availability, Nutritional Intervention, Functional Food, Nutrition Physiology
    View official trial listing →
  • Completed NCT NCT03903081

    The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects

    Not yet reported Sunshine Lake Pharma Co., Ltd. 93 participants Est. completion 2019-10-29 1 site
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT03910673

    Intravenous Fosfomycin Pharmacokinetics Study

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 39 participants Est. completion 2020-12-17 1 site
    Other conditions: Bacterial Infection, Multiple-drug Resistance, Pathogen Resistance
    View official trial listing →
  • Status unknown NCT NCT03944044

    Paracetamol Route in Palliative Care Patients (PARASCIVPALLIA)

    Not yet reported University Hospital, Caen 20 participants Est. completion 2024-03-01 1 site
    Other conditions: Palliative Care
    View official trial listing →
  • Completed NCT NCT03962049

    Safety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic Function

    Not yet reported ObsEva SA 24 participants Est. completion 2019-11-01 2 sites
    Other conditions: Hepatic Impairment, Healthy Participants
    View official trial listing →
  • Active, not recruiting NCT NCT03987763

    A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

    Not yet reported Bausch Health Americas, Inc. 45 participants Est. completion 2027-04 9 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT03988439

    A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

    Not yet reported Bausch Health Americas, Inc. 16 participants Est. completion 2026-02-06 9 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Active, not recruiting NCT NCT04003805

    Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users

    Not yet reported Masonic Cancer Center, University of Minnesota 47 participants Est. completion 2026-08-20 1 site Stand-alone
    Other conditions: Smoking, Cigarette
    View official trial listing →
  • Status unknown NCT NCT04060836

    Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 24 participants Est. completion 2020-03 5 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT04088604

    Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors

    Not yet reported Luye Pharma Group Ltd. 38 participants Est. completion 2021-12-17 1 site
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Completed NCT NCT04096950

    Safety and Pharmacokinetics Study of MT-3921 in Spinal Cord Injury

    Not yet reported Tanabe Pharma America, Inc. 3 participants Est. completion 2021-01-06 13 sites
    Other conditions: Spinal Cord Injury
    View official trial listing →
  • Completed NCT NCT04098692

    Mass Balance and Pharmacokinetics Study of Derazantinib in Healthy Male Subjects

    Not yet reported Basilea Pharmaceutica 12 participants Est. completion 2019-11-18 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Terminated NCT NCT04110496

    Safety and Tolerability of RTX-134 in Adults With Phenylketonuria

    Not yet reported Rubius Therapeutics 1 participants Est. completion 2022-12-01 1 site
    Other conditions: Phenylketonurias
    View official trial listing →
  • Completed NCT NCT04162275

    A Single-dose Study to Investigate the Tolerance and Pharmacokinetics of Finamine Tablets in China

    Not yet reported Yiling Pharmaceutical Inc. 34 participants Est. completion 2018-04-27 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04164121

    A Clinical Study Trial of Phenlarmide in China

    Not yet reported Yiling Pharmaceutical Inc. 36 participants Est. completion 2020-12-02 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04219865

    Safety, Tolerance and Pharmacokinetics Study of Compound Edaravone Injection

    Not yet reported Nanjing Yoko Biomedical Co., Ltd. 40 participants Est. completion 2019-08-16 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT04229394

    2ccPA Study in Patients With Symptomatic Knee Osteoarthritis

    Not yet reported Orient Europharma Co., Ltd. 40 participants Est. completion 2021-03-22 5 sites
    Osteoarthritis
    View official trial listing →
  • Status unknown NCT NCT04230057

    Pharmacokinetics Study of Antitumor B in Healthy Volunteers

    University of Houston 12 participants Est. completion 2021-08-30 1 site
    Other conditions: Healthy Adults
    View official trial listing →
  • Completed NCT NCT04244448

    Bioequivalence of Solid/Crushed/Dissolved Forms of Biktarvy®

    Not yet reported University Hospital, Caen 18 participants Est. completion 2021-05-31 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Terminated NCT NCT04258592

    18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

    Not yet reported Universitaire Ziekenhuizen KU Leuven 6 participants Est. completion 2022-07-07 1 site Stand-alone
    Other conditions: Neural Crest Tumor, Neuroendocrine Tumors
    View official trial listing →
  • Status unknown NCT NCT04277143

    A Pharmacokinetics Study of Daptomycin in Critically Ill Patients and Effects of Daptomycin on Kidney

    Zhongnan Hospital 120 participants Est. completion 2022-12-31 1 site
    Other conditions: Outcome, Fatal, Infection
    View official trial listing →
  • Completed NCT NCT04283097

    Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects

    Not yet reported Kangpu Biopharmaceuticals, Ltd. 30 participants Est. completion 2024-12-12 10 sites
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT04328077

    LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)

    Not yet reported Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 101 participants Est. completion 2021-05-19 31 sites
    MASH
    View official trial listing →
  • Terminated NCT NCT04346667

    Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds

    Not yet reported Government of Punjab, Specialized Healthcare and Medical Education Department 125 participants Est. completion 2020-08-30 3 sites
    Other conditions: SARS-CoV-2, Coronavirus Infection, Asymptomatic Condition, COVID-19
    View official trial listing →
  • Terminated NCT NCT04351191

    PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds

    Not yet reported Government of Punjab, Specialized Healthcare and Medical Education Department 137 participants Est. completion 2020-08-30 4 sites
    Other conditions: Sars-CoV2, Symptomatic Condition, Covid-19
    View official trial listing →
  • Status unknown NCT NCT04420234

    A Pharmacokinetics and Safety Study of Narfurine Hydrochloride Orally Disintegrating Tablets

    Not yet reported First Affiliated Hospital of Zhejiang University 30 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Improvement of Pruritus in Hemodialysis Patients
    View official trial listing →
  • Completed NCT NCT04442945

    Phase 1 Study of ANAVEX3-71

    Not yet reported Anavex Life Sciences Corp. 36 participants Est. completion 2021-10-30 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04471038

    Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants

    Not yet reported SAb Biotherapeutics, Inc. 27 participants Est. completion 2021-04-19 1 site
    Other conditions: Influenza Type A, Influenza Type B, Influenza
    View official trial listing →
  • Completed NCT NCT04479631

    Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196

    Not yet reported Brii Biosciences Limited 16 participants Est. completion 2021-01-29 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04479644

    Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198

    Not yet reported Brii Biosciences Limited 17 participants Est. completion 2021-02-03 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04499209

    Pharmacokinetics Study of XG005 Capsule

    Not yet reported Xgene Pharmaceutical Group 50 participants Est. completion 2018-03-19 1 site
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT04501250

    Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method

    Not yet reported Geropharm 52 participants Est. completion 2018-05-21 1 site
    Other conditions: Pharmacokinetics, Bioequivalence
    View official trial listing →
  • Completed NCT NCT04506905

    Safety, Tolerability, and Pharmacokinetics Study of Elpipodect (MK-8189) in Participants With Schizophrenia and Healthy Participants (MK-8189-011)

    Not yet reported Merck Sharp & Dohme LLC 63 participants Est. completion 2022-03-22 6 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT04513340

    WD-1603 PK Study Under Fasting and Fed Conditions in Healthy Subjects

    Not yet reported Hong Kong WD Pharmaceutical Co., Limited 8 participants Est. completion 2021-02-13 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04529811

    Randomised, Placebo-controlled Safety and Pharmacokinetics Study of Novel Rifaximin Formulations in Healthy Volunteers

    Not yet reported Bausch Health Americas, Inc. 124 participants Est. completion 2021-05-09 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04591301

    The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects

    Not yet reported Sunshine Lake Pharma Co., Ltd. 69 participants Est. completion 2019-12-06 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT04622111

    Safety and Pharmacokinetics Study of CPL207280 Compound in Healthy Volunteers.

    Not yet reported Celon Pharma SA 68 participants Est. completion 2021-05-05 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04623814

    the Safety, Tolerability, and Pharmacokinetics Study of HEC113995

    Not yet reported Sunshine Lake Pharma Co., Ltd. 58 participants Est. completion 2020-08-12 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT04644003

    Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder (ASD)

    Not yet reported Stalicla SA 12 participants Est. completion 2022-01-28 1 site
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Completed NCT NCT04651153

    A Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parkinson's Disease (PD)

    Not yet reported UCB Biopharma SRL 62 participants Est. completion 2023-07-20 2 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT04676178

    A Study of PRA023 in Healthy Volunteers

    Not yet reported Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 69 participants Est. completion 2021-09-23 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04746547

    Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB

    Not yet reported University of KwaZulu 20 participants Est. completion 2025-07-31 1 site
    Other conditions: Tuberculosis, Hiv
    View official trial listing →
  • Completed NCT NCT04783766

    Safety, Tolerability and Pharmacokinetics Study of CK-3773274

    Not yet reported Corxel Pharmaceuticals 28 participants Est. completion 2021-08-05 1 site
    Other conditions: Obstructive Hypertrophic Cardiomyopathy, Healthy Adult Subjects
    View official trial listing →
  • Completed NCT NCT04857957

    Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN

    Not yet reported Centrexion Therapeutics 46 participants Est. completion 2023-08-30 1 site
    Other conditions: Painful Diabetic Neuropathy
    View official trial listing →
  • Status unknown NCT NCT04890587

    A Phase I Study of AL8326 in Advanced Solid Tumor

    Not yet reported Advenchen Laboratories Nanjing Ltd. 40 participants Est. completion 2023-12 2 sites
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT04903730

    Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution

    Not yet reported Aerami Therapeutics 83 participants Est. completion 2022-12-02 1 site
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT04993157

    Pharmacokinetics Study of FIA586 in Participants With Mild and Moderate Hepatic Impairment

    Not yet reported Novartis Pharmaceuticals 54 participants Est. completion 2022-06-28 2 sites
    Other conditions: Hepatic Impairment
    View official trial listing →
  • Completed NCT NCT05018533

    The Safety and Pharmacokinetics Study of TAKC-02 Inhalation Solution in Healthy Adult Males.

    Not yet reported TAK-Circulator Co. 52 participants Est. completion 2021-12-28 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT05032560

    Safety and Pharmacokinetics Study in Healthy Japanese Volunteers

    Not yet reported Abivax S.A. 48 participants Est. completion 2022-02-18 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05046808

    Pharmacokinetics Study of Famitinib Malate Capsules in Healthy Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 70 participants Est. completion 2021-11-22 1 site
    Other conditions: Solid Tumor
    View official trial listing →
  • Withdrawn NCT NCT05048368

    Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function

    Not yet reported Sunshine Lake Pharma Co., Ltd. Est. completion 2026-12-30 1 site
    Other conditions: Esophageal Cancer, Advanced Solid Tumor
    View official trial listing →
  • Completed NCT NCT05076838

    Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy

    Not yet reported, Not yet reported Neurelis, Inc. 36 participants Est. completion 2025-03-11 13 sites
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT05083260

    NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa

    Not yet reported, Not yet reported BioVie Inc. 46 participants Est. completion 2023-01-04 16 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05091723

    TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation

    Not yet reported Theravance Biopharma 14 participants Est. completion 2021-11-24 1 site
    Other conditions: Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19)
    View official trial listing →
  • Completed NCT NCT05122260

    PREVENT-COVID-19: A Q-Griffithsin Intranasal Spray

    Not yet reported Kenneth Palmer 18 participants Est. completion 2022-02-14 1 site
    Other conditions: COVID-19 Prevention
    View official trial listing →
  • Completed NCT NCT05169671

    Safety, Tolerability, and Pharmacokinetics Study of ATH-1020

    Not yet reported LeonaBio 32 participants Est. completion 2022-09-09 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05201690

    Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV116 in Healthy Volunteers

    Not yet reported Vigonvita Life Sciences 36 participants Est. completion 2022-01-23 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Active, not recruiting NCT NCT05222555

    Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients

    Not yet reported, Not yet reported Incyte Corporation 53 participants Est. completion 2027-11-30 62 sites
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT05223660

    A Phase I Pharmacokinetics Study for KT07 Capsule

    Not yet reported Yiling Pharmaceutical Inc. 26 participants Est. completion 2022-09-06 1 site
    Other conditions: Healthy Adult Subjects, Pharmacokinetics, Safety and Tolerability
    View official trial listing →
  • Completed NCT NCT05227768

    Safety and Pharmacokinetics Study of Single Ascending Doses of VV116 in Healthy Volunteers

    Not yet reported Vigonvita Life Sciences 38 participants Est. completion 2022-01-13 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT05248776

    Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes

    Not yet reported Celon Pharma SA 80 participants Est. completion 2023-06-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05278156

    Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia

    Not yet reported Celon Pharma SA 189 participants Est. completion 2024-06-19 16 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT05317078

    A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

    Not yet reported Amgen 3 participants Est. completion 2024-04-01 8 sites
    Alcohol use disorder Other conditions: Non-squamous Non-small Cell Lung Cancer, Epithelial Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT05360576

    An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study

    Not yet reported Lupin Research Inc 40 participants Est. completion 2022-07-04 1 site
    Other conditions: Pregnancy Prevention
    View official trial listing →
  • Completed NCT NCT05393856

    CG-549 Tablet Pharmacokinetics Study

    Not yet reported CrystalGenomics, Inc. 24 participants Est. completion 2020-06-30 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05397379

    A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis

    Not yet reported Sunshine Lake Pharma Co., Ltd. 68 participants Est. completion 2023-09-05 9 sites
    Other conditions: Non-Alcoholic Steatohepatitis
    View official trial listing →
  • Status unknown NCT NCT05461287

    Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors

    Not yet reported Qilu Pharmaceutical Co., Ltd. 290 participants Est. completion 2025-05-25 1 site
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Status unknown NCT NCT05488821

    Safety, Tolerability and Pharmacokinetics Study of QLH11906 in Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations.

    Not yet reported Qilu Pharmaceutical Co., Ltd. 40 participants Est. completion 2025-07-01 1 site
    Other conditions: Advanced Solid Tumors Harboring MAPK Pathway Alterations
    View official trial listing →
  • Completed NCT NCT05503693

    A Safety, Tolerability, and Pharmacokinetics Study of AP303 in Healthy Subjects

    Not yet reported Alebund Pty Ltd 62 participants Est. completion 2023-07-21 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT05524311

    Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)

    Not yet reported Assistance Publique - Hôpitaux de Paris 16 participants Est. completion 2026-01-02 13 sites Stand-alone
    Other conditions: Juvenile Dermatomyositis
    View official trial listing →
  • Withdrawn NCT NCT05541159

    Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

    Not yet reported Novartis Pharmaceuticals Est. completion 2025-07-15
    Other conditions: Renal Impairment
    View official trial listing →
  • Completed NCT NCT05542303

    A Safety, Tolerability and Pharmacokinetics Study of ZB001 in Healthy Subjects

    Not yet reported Zenas BioPharma (USA), LLC 24 participants Est. completion 2023-04-04 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05603182

    A Study of PRA052 in Healthy Volunteers

    Not yet reported Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 96 participants Est. completion 2024-02-21 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05605301

    Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy

    Not yet reported University of Virginia 9 participants Est. completion 2024-02-05 1 site
    Other conditions: Epilepsy; Seizure
    View official trial listing →
  • Status unknown NCT NCT05610202

    Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 137 participants Est. completion 2024-08 2 sites
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Completed NCT NCT05687500

    Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)

    Not yet reported Assistance Publique - Hôpitaux de Paris 35 participants Est. completion 2026-01-08 1 site Stand-alone
    Other conditions: Transient; Hypoglycemia, Neonatal, Preterm, Glibenclamide Adverse Reaction
    View official trial listing →
  • Completed NCT NCT05718921

    A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers

    Not yet reported Hangzhou Yirui Pharmaceutical Technology Co., Ltd 54 participants Est. completion 2023-12-14 1 site
    Other conditions: Atopic Dermatitis, Psoriasis
    View official trial listing →
  • Status unknown NCT NCT05719961

    Bioequivalence Study of INS062 and Pharmacokinetics and Pharmacokinetics Study of Single Injection of HR20014 in Healthy Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 60 participants Est. completion 2023-07-30 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT05794516

    A Safety and Pharmacokinetics Study of ZB004 in Healthy Participants

    Not yet reported Zenas BioPharma (USA), LLC 40 participants Est. completion 2024-03-21 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT05807217

    A Pharmacokinetics Study of Meropenem and Piperacillin in Patients With Sepsis

    Shen Ning 44 participants Est. completion 2023-12-31 1 site
    Other conditions: Sepsis, Acute Kidney Injury
    View official trial listing →
  • Completed NCT NCT05819736

    Pharmacokinetics Study Of Rivaroxaban and Apixaban in Cancer Patients

    Groupe Hospitalier Pitie-Salpetriere 193 participants Est. completion 2026-05-18 1 site
    Other conditions: Anticoagulants and Thrombotic Disorders
    View official trial listing →
  • Completed NCT NCT05829551

    The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult Participants

    Not yet reported Guangdong Raynovent Biotech Co., Ltd 88 participants Est. completion 2022-08-12 1 site
    Other conditions: COVID-19 (Coronavirus Disease 2019)
    View official trial listing →
  • Completed NCT NCT05864573

    Study of ZGGS15 in Patients With Advanced Solid Tumors

    Not yet reported Suzhou Zelgen Biopharmaceuticals Co.,Ltd 22 participants Est. completion 2025-06-26 1 site
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT05872958

    Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study

    Not yet reported AstraZeneca 98 participants Est. completion 2024-08-20 4 sites
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT06049771

    The Population Pharmacokinetics Study of Tigecycline and Pharmacokinetics- Pharmacodynamics Index in Patients With Carbapenem Resistant Enterobacteriaceae Bloodstream Infection

    Not yet reported Phramongkutklao College of Medicine and Hospital 72 participants Est. completion 2025-06-30 1 site
    Other conditions: Carbapenem-resistant Enterobacteriaceae
    View official trial listing →
  • Active, not recruiting NCT NCT06093269

    Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL)

    Not yet reported University Hospital, Tours 32 participants Est. completion 2025-12 2 sites
    Other conditions: Hemodialysis Catheter Infection, Infection, Bacterial
    View official trial listing →
  • Completed NCT NCT06141889

    Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers

    Not yet reported BioAge Labs, Inc. 16 participants Est. completion 2024-02-02 1 site
    Other conditions: Healthy Volunteer Study
    View official trial listing →
  • Status unknown NCT NCT06171048

    Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects

    Not yet reported Keymed Biosciences Co.Ltd 236 participants Est. completion 2025-04-30 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT06171724

    Ashwagandha Pharmacokinetics Study in Older Adults

    Not yet reported Oregon Health and Science University 11 participants Est. completion 2024-12-09 1 site
    Other conditions: Healthy, Aging
    View official trial listing →
  • Status unknown NCT NCT06233292

    A Study of ZG005 in Patients With Advanced Solid Tumors

    Not yet reported, Not yet reported Suzhou Zelgen Biopharmaceuticals Co.,Ltd 484 participants Est. completion 2026-01 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT06246175

    A Study of HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects

    Not yet reported Fujian Shengdi Pharmaceutical Co., Ltd. 32 participants Est. completion 2025-09-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06279533

    Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules

    Not yet reported Vigonvita Life Sciences 49 participants Est. completion 2024-12-17 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Suspended NCT NCT06310811

    Anti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus Erythematosus

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12 participants Est. completion 2027-03-01 1 site
    Other conditions: Safety, Effective
    View official trial listing →
  • Withdrawn NCT NCT06411639

    Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases

    Not yet reported Novartis Pharmaceuticals Est. completion 2028-06-24
    Other conditions: Sjogren Disease, Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT06481215

    A Safety and Pharmacokinetics Study of Ustekinumab Biosimilar GNR-068 and Stelara® in Healthy Volunteers

    Not yet reported AO GENERIUM 122 participants Est. completion 2022-12-20 2 sites
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06488521

    A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy Volunteers

    Not yet reported AO GENERIUM 256 participants Est. completion 2025-07-28 3 sites
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06492135

    A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body

    Not yet reported Boehringer Ingelheim 30 participants Est. completion 2025-04-15 1 site
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT06496217

    Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

    Not yet reported MBX Biosciences 25 participants Est. completion 2025-09-04 3 sites
    Other conditions: Renal Impairment
    View official trial listing →
  • Completed NCT NCT06527937

    Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome

    Not yet reported Aquestive Therapeutics 36 participants Est. completion 2024-10-13 1 site
    Other conditions: Allergic Reaction
    View official trial listing →
  • Completed NCT NCT06570668

    Safety, Tolerability and Pharmacokinetics of CDD-2101 in Health Volunteers

    Not yet reported Centre for Chinese Herbal Medicine Drug Development Limited 20 participants Est. completion 2024-07-12 1 site
    Other conditions: Constipation - Functional
    View official trial listing →
  • Completed NCT NCT06593457

    A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects

    Not yet reported Nurix Therapeutics, Inc. 32 participants Est. completion 2024-11-14 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06727838

    Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 18 participants Est. completion 2025-01-25 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT06775834

    Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 24 participants Est. completion 2025-07-23 1 site
    Other conditions: Hypertrophic Cardiomyopathy
    View official trial listing →
  • Active, not recruiting NCT NCT06867796

    A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults

    Not yet reported TrueLab Biopharmaceutical Co., Ltd 48 participants Est. completion 2028-12 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06883656

    The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency

    Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 18 participants Est. completion 2022-11-01 1 site
    Type 2 diabetes Other conditions: Renal Insuficiency
    View official trial listing →
  • Completed NCT NCT06929156

    A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function

    Not yet reported BrightGene Bio-Medical Technology Co., Ltd. 34 participants Est. completion 2025-12-25 1 site
    Type 2 diabetes Other conditions: Overweight or Obese
    View official trial listing →
  • Completed NCT NCT06964711

    GW117 ODT （Orally Disintegrating Tablets） Safety and Pharmacokinetics Study in Healthy Subjects

    Not yet reported Beijing Greatway Pharmaceutical Technology Co.,Ltd. 92 participants Est. completion 2023-03-24 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Not yet recruiting NCT NCT06980909

    The Food Effect on Pharmacokinetics Study of QLC1101 in Healthy Subjects

    Not yet reported Qilu Pharmaceutical Co., Ltd. 18 participants Est. completion 2025-08
    Other conditions: Effect of Food
    View official trial listing →
  • Not yet recruiting NCT NCT07053020

    A Phase 1 Open-Label, Dose-Ranging Safety and Pharmacokinetics Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 58 participants Est. completion 2030-06-30 1 site
    Other conditions: Acute Myeloid Leukemia (AML)
    View official trial listing →
  • Completed NCT NCT07056517

    Pharmacokinetics and Safety of M107 Orally Disintegrating Tablet in Healthy Adults

    Not yet reported Aclipse Two Inc. 21 participants Est. completion 2025-09-22 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT07155668

    A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

    Not yet reported Viridian Therapeutics, Inc. 87 participants Est. completion 2026-05-28 13 sites
    Other conditions: Thyroid Eye Disease
    View official trial listing →
  • Completed NCT NCT07282145

    Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers

    Not yet reported Bichedam Co., Ltd. 57 participants Est. completion 2026-05-15 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Terminated NCT NCT07431398

    Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease

    Not yet reported Fulcrum Therapeutics 13 participants Est. completion 2026-06-01 6 sites
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07690124

    S-Acetyl Glutathione and Performance Recovery in Soccer

    Not yet reported University of Thessaly 20 participants Est. completion 2027-01-20 1 site
    Other conditions: Performance Recovery, Exercise-induced Inflammation, Exercise-induced Oxidative Stress
    View official trial listing →
  • Not yet recruiting NCT NCT07710326

    Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV261 Tablets

    Not yet reported Vigonvita Life Sciences 16 participants Est. completion 2026-11-30 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT07809919

    A First-in-human, Safety, Tolerability, and Pharmacokinetics Study of LXE408 in Healthy Subjects

    Not yet reported Novartis Pharmaceuticals 88 participants Est. completion 2021-09-27 1 site
    Other conditions: Visceral Leishmaniasis, Chagas Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07859423

    A Study to Investigate AG-236 in Subjects ≥18 Years of Age With Polycythemia Vera

    Not yet reported, Not yet reported Agios Pharmaceuticals, Inc. 245 participants Est. completion 2032-08
    Other conditions: Polycythemia Vera
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.